These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20413845)

  • 1. Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.
    Lucci MA; Orlandi R; Triulzi T; Tagliabue E; Balsari A; Villa-Moruzzi E
    Cell Oncol; 2010; 32(5-6):361-72. PubMed ID: 20413845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
    González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
    Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.
    Villa-Moruzzi E
    Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genome wide analysis of protein tyrosine phosphatases identifies CDC25C as prognostic and predictive marker for chemoresistance in breast cancer.
    Topno R; Nazam N; Kumari P; Kumar M; Agarwal P
    Cancer Biomark; 2021; 32(4):491-504. PubMed ID: 34275890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways.
    Siddiqa A; Long LM; Li L; Marciniak RA; Kazhdan I
    BMC Cancer; 2008 May; 8():129. PubMed ID: 18454859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The positive is inside the negative: HER2-negative tumors can express the HER2 intracellular domain and present a HER2-positive phenotype.
    Panis C; Pizzatti L; Corrêa S; Binato R; Lemos GF; da Silva do Amaral Herrera AC; Seixas TF; Cecchini R; Abdelhay E
    Cancer Lett; 2015 Feb; 357(1):186-195. PubMed ID: 25434795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.
    Scrima M; De Marco C; De Vita F; Fabiani F; Franco R; Pirozzi G; Rocco G; Malanga D; Viglietto G
    Am J Pathol; 2012 Mar; 180(3):1202-1214. PubMed ID: 22245727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
    Wiener JR; Kassim SK; Yu Y; Mills GB; Bast RC
    Gynecol Oncol; 1996 May; 61(2):233-40. PubMed ID: 8626139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells.
    Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista VP; Fuentes-Mera L; Romero-Zamora D; Maciel-Dominguez A; de la Cruz OH; Fonseca-Sánchez M; Ruíz-García E; la Vega HA; López-Camarillo C
    BMC Cancer; 2016 Jul; 16():379. PubMed ID: 27377268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.
    Wang X; Wong J; Sevinsky CJ; Kokabee L; Khan F; Sun Y; Conklin DS
    Mol Cancer Ther; 2016 Sep; 15(9):2198-208. PubMed ID: 27256378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
    Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
    Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
    Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification.
    Magnifico A; Albano L; Campaner S; Campiglio M; Pilotti S; Ménard S; Tagliabue E
    Cancer Res; 2007 Jun; 67(11):5308-17. PubMed ID: 17545611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    Niu G; Carter WB
    Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
    Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
    Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.
    Rahmatpanah FB; Jia Z; Chen X; Char JE; Men B; Franke AC; Jones FE; McClelland M; Mercola D
    Oncotarget; 2015 Jan; 6(2):1286-301. PubMed ID: 25428913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.